期刊文献+

抗抑郁症类药物的临床应用研究进展 被引量:26

Progress in clinical use of antidepressant
下载PDF
导出
摘要 抑郁症有其生物学基础,如脑内神经递质和神经内分泌功能的改变,下丘脑-垂体-肾上腺(HPA)轴负反馈失调和神经免疫异常等。近年来,抗抑郁症类药物随着抑郁症病理生理学研究的深入而逐渐发展。本文对抗抑郁药临床应用等进行了综述。 change Depression is based on some biological theories, such as of neurotransmitter and hormone secretion in brain tissue, dysfuction of hypothalamic - pituitary - adrenal systerm negative - feedback and neuroimmunologic abnormality et al. Recently, followed study of depressive pathophysiology, pharmacological management of depression has made some progeress. In this review, biological theories of depression and clinical usage of antidepressant are discussed.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2007年第1期54-57,共4页 The Chinese Journal of Clinical Pharmacology
关键词 抑郁症 病理机制 抗抑郁药 depression mechanism antidepressant
  • 相关文献

参考文献15

  • 1季建林,张虹复.抑郁症躯体症状及其相关因素分析[J].中国心理卫生杂志,2002,16(9):605-608. 被引量:46
  • 2Word Health Organization.The world health report 2001.Mental health:new understanding,new hope[J/OL].http://www.who.int/ whr,2001-11 -01.
  • 3屈娅,冯正直.下丘脑-垂体-肾上腺轴在抑郁症发病中的作用[J].局解手术学杂志,2004,13(1):57-60. 被引量:16
  • 4Rothermundt M,Arolt V,Fenker J,et al.Different immune patters in melancholic and non-melancholic major depression[J].Eur Arch Psychiatry Clin Neurosci,2001 ;251:90-97.
  • 5Svenningsson P,Chergui R,Rachleff I,et al.Alterations in 5 -HT1B receptor function by p11 in depression -like states[J].Science,2006;5757 (311):77 -80.
  • 6Tang HB,Inoue A,Iwasa M,et al.Substance P release evoked by capsaicin or potassium from rat cultured dorsal root ganglion neurons is conversely modulated with bradykinin[J].J Neurochem,2006 ;97:1412 -1418.
  • 7Schdev PS,Parslow RA,Lux O,et al.Relationship of homocysteine,folic acid and vitamin B12 with depression in a middle-aged community sample[J].Psychol Med,2005 ;35:529 -538.
  • 8吕路线,郭本玉,赵靖平.吗氯贝胺治疗抑郁症[J].中国新药与临床杂志,2001,20(1):16-18. 被引量:17
  • 9Jureidini JN,Tonkin Al.Clinical practice guidelines for depression in young people[J].Med J Aust,2003; 178:300-302.
  • 10Moses-Kolko EL,Bogen D,Perel J,et al.Neonatal signs after late in utero exposure to serotonin reuptake inhibitors:literature review and implications for clinical applications[J].JAMA,2005; 293:2372-2383.

二级参考文献22

  • 1曾昭祥,黄建军,张永东,李志成,陈景清,高诚.曲米帕明与米帕明治疗抑郁症的对比[J].新药与临床,1995,14(1):18-20. 被引量:1
  • 2李一云,季建林.对抑郁症预后的再认识[J].国外医学(精神病学分册),1996,23(3):148-152. 被引量:42
  • 3Raadsheer FC ,Hoogendijk WJ, Stam FC,et al.Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular pressed patients[J]. Neuroendocrinology, 1994, 60(4): 436-444.
  • 4Hauger RL, Shelat SG, Redei EE. Decreased corticotropin-releasing factor receptor expression and adrenocorticotropic hormone responsiveness in anterior pituitarys cells of Wistar-Kyoto rats[J]. J Neuroendocrinol, 2002, 14(2): 126-134.
  • 5Hoogendijk WJ,PurbaJS,Hofman MA,et al. Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus[J]. Biol Psychiatry,1998,43(12): 913-917.
  • 6Steiger A,Holsboer F. Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acute episode and after full remission[J]. Psychiatry Res,1997,72(2): 81-88.
  • 7McAllister-Williams R H, Ferrier IN,Young AH.Mood and neuropsychological function in depression: the role of corticosteroids and serotonin[J].Psycho Med ,1998,28(3):573-584.
  • 8Arborelius L,Owens MJ,Plotsky PM. The role of corticotropin-releasing factor in depression and anxiety disorders[J]. J Endocrinol, 1999, 160(1): 1-12.
  • 9Pepin MC,Pothier F,Barden N.Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression[J].Mol Pharmacol. 1992, 42(6): 991-995.
  • 10Barden N. Regulation of corticosteroid receptor gene expression in depression and antidepressant action[J].J Psychiatry Neurosci, 1999, 24(1): 25-39.

共引文献75

同被引文献224

引证文献26

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部